Roberto Ríos‐Garcés

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry

Jaume Alijotas‐Reig, Enrique Esteve‐Valverde, Raquel Ferrer‐Oliveras et al. · Lara D. Veeken · 2019 · 97 citations · Full text

Medicine, Hematology, Obstetrics +14

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis

Marc Corbera‐Bellalta, Roser Alba-Rovira, Sujatha Muralidharan et al. · Annals of the Rheumatic Diseases · 2022 · 55 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Treatment of Uterine Myoma with 2.5 or 5 mg Mifepristone Daily during 3 Months with 9 Months Posttreatment Followup: Randomized Clinical Trial

Josep Lluis Carbonell, Rita Acosta, Yasmirian Pérez et al. · ISRN Obstetrics and Gynecology · 2013 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)

Xin Wang, Elena Gkrouzman, Danieli Andrade et al. · Lupus · 2021 · 29 citations · Full text

Medicine, Hematology, Pathology +17

Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis

Roberto Ríos‐Garcés, Sergio Prieto‐González, José Hernández‐Rodríguez et al. · European Journal of Internal Medicine · 2021 · 25 citations · Full text

Life Sciences, Clinical Sciences, Pharmacotherapy +17